Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Rating of “Hold” from Analysts
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have earned an average rating of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating on […]
5 Jul 10:44 · The Cerbat Gem